Financial

MUFG Innovation Partners contributed to mobility financier Moove's $105m series A2 round while MS&AD and Nationwide helped insurance software developer Socotra raise $50m.

Unfavourable market conditions have scuppered the corporate-backed consumer credit company’s planned reverse takeover as it opts instead for more private funding.

SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.

GV returned for a multimillion dollar round raised by the clinical data software provider, which is part of a space of much interest to corporate investors.

Lunar expanded its series D round to $307m while RefleXion Medical raised $80m and Silent Eight raked in $40m.

The newly minted Cake DeFi Ventures, will invest in gaming, Web3 and financial technology developers on behalf of its decentralised finance parent.

GV and Animoca Brands helped earphone developer Nothing secure $70m while Cialfo bumped its Seek-backed series B round up to $60m.

The financial services provider’s Ganesha Fund will focus on India-based fintech and IT startups that can help develop new products and digitalise its core business.

JPMorgan Chase and Salesforce Ventures took part in financial services provider Propel's $50m series B round while prayer app developer Glorify closed its second $40m round in three months.

Banking software provider Zeta netted $30m from investors including Mastercard at a $1.5bn valuation while drug development services provider Staq Pharma closed its series C round.

The corporate venturing industry is pushing towards a 50:50 split in senior investor roles.